[Therapeutic activity of a betamethasone dipropionate and salicylic acid combination in dermatology].
D000293:Adolescent; D000328:Adult; D001623:Betamethasone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002648:Child; D012628:Dermatitis, Seborrheic / Q000188:drug therapy*; D004338:Drug Combinations; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy*; D012459:Salicylates / Q000627:therapeutic use*; D020156:Salicylic Acid
D004338:Drug Combinations; D012459:Salicylates; C011175:betamethasone-17,21-dipropionate; D001623:Betamethasone; D020156:Salicylic Acid
Attività terapeutica dell'associazione betametasone dipropionato ed acido salicilico in dermatologia.